Literature DB >> 20230750

Regulation of developmental lymphangiogenesis by Syk(+) leukocytes.

Ruben Böhmer1, Brit Neuhaus, Sebastian Bühren, Dayong Zhang, Martin Stehling, Barbara Böck, Friedemann Kiefer.   

Abstract

Lymphatic vessels are essential for tissue homeostasis and immune surveillance and contribute to pathological conditions. Lymphatic endothelium differentiates from veins and forms an independent vascular tree with only few connections to the venous circulation. Failure of blood and lymphatic vessel separation results in hemorrhage and edema. VEGF-C and -D are strong inducers of lymphangiogenesis and have essential (VEGF-C) and modulatory (VEGF-D) roles during developmental lymphangiogenesis. We describe here a myeloid population that is defined by expression of the tyrosine kinase Syk, comprises largely M2-polarized mononuclear cells, and robustly expresses angiogenic factors, including VEGF-C/-D and chemokines. These cells stimulate lymphangiogenesis in vivo. Deletion of Syk causes increased chemotractant production, enhanced transmigration, and accumulation in the skin. Ensuing lymphatic hyperplasia and vessel dilation cause the formation of blood-lymphatic shunts. This mechanism does not involve circulating endothelial progenitor cells and demonstrates the potential of hematopoietic cells to control developmental lymphangiogenesis. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230750     DOI: 10.1016/j.devcel.2010.01.009

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  38 in total

Review 1.  Myeloid cells and lymphangiogenesis.

Authors:  Adrian Zumsteg; Gerhard Christofori
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

3.  De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice.

Authors:  Kerstin Buttler; Muhammad Badar; Virginia Seiffart; Sandra Laggies; Gerhard Gross; Jörg Wilting; Herbert A Weich
Journal:  Cell Mol Life Sci       Date:  2013-09-01       Impact factor: 9.261

4.  Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.

Authors:  Kate L Lowe; Brenda A Finney; Carsten Deppermann; René Hägerling; Salomé L Gazit; Jon Frampton; Christopher Buckley; Eric Camerer; Bernhard Nieswandt; Friedemann Kiefer; Steve P Watson
Journal:  Blood       Date:  2015-04-23       Impact factor: 22.113

5.  Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.

Authors:  Brit Neuhaus; Sebastian Bühren; Barbara Böck; Frauke Alves; Wolfgang F Vogel; Friedemann Kiefer
Journal:  Cell Mol Life Sci       Date:  2011-04-17       Impact factor: 9.261

6.  Fusing VE-cadherin to α-catenin impairs fetal liver hematopoiesis and lymph but not blood vessel formation.

Authors:  Nina Dartsch; Dörte Schulte; René Hägerling; Friedemann Kiefer; Dietmar Vestweber
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

7.  The BAFFling function of Syk in B-cell homeostasis.

Authors:  Sebastian Königsberger; Friedemann Kiefer
Journal:  EMBO J       Date:  2015-02-20       Impact factor: 11.598

Review 8.  Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis.

Authors:  Rui-Cheng Ji
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

9.  Deletion of Syk in neutrophils prevents immune complex arthritis.

Authors:  Emily R Elliott; Jessica A Van Ziffle; Patrizia Scapini; Brandon M Sullivan; Richard M Locksley; Clifford A Lowell
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

10.  Pharmacological manipulation of blood and lymphatic vascularization in ex vivo-cultured mouse embryos.

Authors:  Martin Zeeb; Jennifer Axnick; Lara Planas-Paz; Thorsten Hartmann; Boris Strilic; Eckhard Lammert
Journal:  Nat Protoc       Date:  2012-10-11       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.